Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
$0.90
+1.1%		$1.02
$0.70
▼
$18.10
$2.98M2.5257,314 shs6,940 shs
Ainos, Inc. stock logo
AIMD
Ainos
$1.60
+2.6%		$1.57
$1.26
▼
$4.44
$11.81M2.4731,677 shs46,678 shs
Boxlight Corporation stock logo
BOXL
Boxlight
$6.09
-0.3%		$4.73
$2.59
▼
$365.40
$4.06M0.93.97 million shs16,908 shs
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
$1.79
-4.8%		$3.03
$0.04
▼
$8.94
$3.31M2.0432.22 million shs366,290 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
0.00%-4.27%-12.62%-15.09%-51.87%
Ainos, Inc. stock logo
AIMD
Ainos
0.00%+13.48%+4.58%-17.95%-57.22%
Boxlight Corporation stock logo
BOXL
Boxlight
0.00%+2.35%+84.55%+49.26%-90.11%
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
-4.79%-23.83%-39.32%-51.75%-48.56%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
$0.90
+1.1%		$1.02
$0.70
▼
$18.10
$2.98M2.5257,314 shs6,940 shs
Ainos, Inc. stock logo
AIMD
Ainos
$1.60
+2.6%		$1.57
$1.26
▼
$4.44
$11.81M2.4731,677 shs46,678 shs
Boxlight Corporation stock logo
BOXL
Boxlight
$6.09
-0.3%		$4.73
$2.59
▼
$365.40
$4.06M0.93.97 million shs16,908 shs
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
$1.79
-4.8%		$3.03
$0.04
▼
$8.94
$3.31M2.0432.22 million shs366,290 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
0.00%-4.27%-12.62%-15.09%-51.87%
Ainos, Inc. stock logo
AIMD
Ainos
0.00%+13.48%+4.58%-17.95%-57.22%
Boxlight Corporation stock logo
BOXL
Boxlight
0.00%+2.35%+84.55%+49.26%-90.11%
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
-4.79%-23.83%-39.32%-51.75%-48.56%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
1.00
Sell$5.77541.11% Upside
Ainos, Inc. stock logo
AIMD
Ainos
1.00
SellN/AN/A
Boxlight Corporation stock logo
BOXL
Boxlight
1.00
SellN/AN/A
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest AGMH, AIMD, BOXL, and TNFA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/28/2026
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D-) ➝ Sell (D)
8/21/2026
Ainos, Inc. stock logo
AIMD
Ainos
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
8/12/2026
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D) ➝ Sell (D-)
7/6/2026
Boxlight Corporation stock logo
BOXL
Boxlight
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 9/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
$30.56M0.10$0.75 per share1.20$12.14 per share0.07
Ainos, Inc. stock logo
AIMD
Ainos
$120K98.40N/AN/A$0.44 per share3.64
Boxlight Corporation stock logo
BOXL
Boxlight
$109.25M0.04N/AN/A($2.13) per share-2.86
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
N/AN/AN/AN/A$286.76 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
$560KN/AN/AN/AN/AN/AN/AN/AN/A
Ainos, Inc. stock logo
AIMD
Ainos
-$14.77M-$2.52N/AN/AN/A-11,912.10%-217.50%-67.87%N/A
Boxlight Corporation stock logo
BOXL
Boxlight
-$23.81M-$80.86N/AN/AN/A-20.96%N/A-23.50%11/12/2026 (Estimated)
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
-$23.36M-$231.00N/AN/AN/AN/A-69.21%-33.98%N/A

Latest AGMH, AIMD, BOXL, and TNFA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
Boxlight Corporation stock logo
BOXL
Boxlight
-$20.16$0.34+$20.50$0.34$30.85 million$25.92 million
8/7/2026Q4 2025
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
N/A$1.18N/A$1.18N/A$5.13 million
8/3/2026Q2 2026
Ainos, Inc. stock logo
AIMD
Ainos
N/A-$0.62N/A-$0.62N/A$0.15 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
N/AN/AN/AN/AN/A
Ainos, Inc. stock logo
AIMD
Ainos
N/AN/AN/AN/AN/A
Boxlight Corporation stock logo
BOXL
Boxlight
N/AN/AN/AN/AN/A
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
0.05
13.27
11.46
Ainos, Inc. stock logo
AIMD
Ainos
N/A
0.13
0.12
Boxlight Corporation stock logo
BOXL
Boxlight
26.20
0.94
0.44
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
N/A
0.93
0.93

Institutional Ownership

CompanyInstitutional Ownership
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
N/A
Ainos, Inc. stock logo
AIMD
Ainos
N/A
Boxlight Corporation stock logo
BOXL
Boxlight
6.49%
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
9.64%

Insider Ownership

CompanyInsider Ownership
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
34.91%
Ainos, Inc. stock logo
AIMD
Ainos
9.79%
Boxlight Corporation stock logo
BOXL
Boxlight
15.41%
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
0.45%
CompanyEmployeesShares OutstandingFree FloatOptionable
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
203.23 million2.10 millionNot Optionable
Ainos, Inc. stock logo
AIMD
Ainos
407.38 million6.66 millionNot Optionable
Boxlight Corporation stock logo
BOXL
Boxlight
180670,000564,000Not Optionable
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
61.85 million1.84 millionN/A

Recent News About These Companies

Reviewing TNF Pharmaceuticals (NASDAQ:TNFA) & One Stop Systems (NASDAQ:OSS)
August 28, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30988922
TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open Today
June 23, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20240724213342/en/TNF-Pharmaceuticals-Formerly-MyMD-Pharmaceuticals-Begins-Trading-Under-New-Nasdaq-Stock-Symbol-TNFA-Effective-Before-Market-Open-Today
Tnf Pharmaceuticals: A Corporate Pivot Under Scrutiny
February 24, 2026  |  newscase.comN
Why did QCLS stock surge over 60% today?
December 4, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/why-did-qcls-stock-surge-over-60-today/ar-AA1RJkpU
Rheumatoid Arthritis Market to Surge by 2034 as Next-Generation Biologics and JAK Inhibitors Gain Traction | DelveInsight
November 5, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/rheumatoid-arthritis-market-surge-2034-223100043.html
Forward Therapeutics Announces First Participants Dosed in Phase 1 Healthy Volunteer Study of FT2109, a Next-Generation TNF Signaling Inhibitor
October 30, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/forward-therapeutics-announces-first-participants-dosed-in-phase-1-healthy-volunteer-study-of-ft2109-a-next-generation-tnf-signaling-inhibitor-1035455199
Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol "QCLS"
September 26, 2025  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2025/09/25/10260815.htm
TNF Pharmaceuticals changes name to Q/C Technologies
September 25, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/tnf-pharmaceuticals-changes-name-to-q-c-technologies/ar-AA1NdUJ1
TNF Pharmaceuticals stock soars after strategic pivot to quantum computing
September 25, 2025  |  investing.comhttps://www.investing.com/news/stock-market-news/tnf-pharmaceuticals-stock-soars-after-strategic-pivot-to-quantum-computing-93CH-4253533
TNF Pharmaceuticals regains compliance with Nasdaq
September 17, 2025  |  msn.comhttps://www.msn.com/en-us/money/topstocks/tnf-pharmaceuticals-regains-compliance-with-nasdaq/ar-AA1MKHkG
TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 17, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250917806538/en/tnf-pharmaceuticals-regains-compliance-with-nasdaq-minimum-bid-price-requirement/
TNF Pharmaceuticals Announces Closing of $7 Million Private Placement
September 4, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250904261260/en/TNF-Pharmaceuticals-Announces-Closing-of-7-Million-Private-Placement/
TNF Pharmaceuticals stock climbs after securing exclusive crypto computing rights
September 2, 2025  |  investing.comhttps://www.investing.com/news/stock-market-news/tnf-pharmaceuticals-stock-climbs-after-securing-exclusive-crypto-computing-rights-93CH-4219545
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
September 2, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250902025594/en/pharmacyte-biotech-inc.-increases-stake-in-tnf-pharmaceuticals-around-recent-license-for-breakthrough-light-speed-computing-platform-for-use-in-cryptocurrency-applications/
TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance
August 29, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/tnf-pharmaceuticals-announces-reverse-stock-131500170.html
TNF Pharmaceuticals announces improved financial position
August 20, 2025  |  msn.comhttps://www.msn.com/en-us/money/news/tnf-pharmaceuticals-announces-improved-financial-position/ar-AA1KQ0Mv
TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation
August 19, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250819482046/en/tnf-pharmaceuticals-strengthens-financial-position-for-growth-and-value-creation/
TNF Pharmaceuticals Inc Ordinary Shares TNFA - Morningstar
July 11, 2025  |  morningstar.comM
Akers files written objection to her Judicial Investigative admonishment
July 4, 2025  |  wvgazettemail.comW
Dorothy Marillyn Akers
July 2, 2025  |  chattanoogan.comC

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGM Group stock logo

AGM Group NASDAQ:AGMH

$0.90 +0.01 (+1.11%)
As of 09/4/2026 03:47 PM Eastern
This is a fair market value price provided by Massive. Learn more.

AGM Group Holdings Inc. operates as a technology company, engages in the research and development of blockchain-oriented ASIC chip in Singapore, Hong Kong, and China. The company offers MetaTrader 5, a futures trading solution; and foreign exchange trading system that provides services to financial institutions. It also engages in the research and development, manufacture, and sales of technology hardware. In addition, the company sells cryptocurrency mining machine and standardized computing equipment, and technical support plans, as well as delivers fintech software services. AGM Group Holdings Inc. was incorporated in 2015 and is based in Wan Chai, Hong Kong.

Ainos stock logo

Ainos NASDAQ:AIMD

$1.60 +0.04 (+2.56%)
As of 09/4/2026 03:59 PM Eastern

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

Boxlight stock logo

Boxlight NASDAQ:BOXL

$6.09 -0.02 (-0.33%)
As of 09/4/2026 04:00 PM Eastern

Boxlight Corporation designs, produces, and distributes interactive technology solutions for the education, health, corporate, military, and government sectors in the Americas, Europe, the Middle East, Africa, and internationally. The company provides interactive and non-interactive flat panel displays and whiteboards, LED video walls, digital signages, classroom audio and campus communication, cameras and other peripherals, and media players; and accessory document cameras, teacher pads for remote control, assessment systems, and front-of-class display products under the Mimio and Clevertouch brands. It also offers MimioStudio Interactive Instructional software that enables the creation, editing, and presentation of interactive instructional lessons and activities; MimioMobile, a software accessory for MimioStudio; Oktopus Instructional and Whiteboarding software, which enables the creation, editing, and presentation of interactive instructional lessons and activities; Notes+, a software accessory; GameZones, a multi-student interactive gaming software; MimioConnect, an online student engagement platform; and LYNX, a lesson building app. In addition, the company provides Juno, a towering standard of sound quality that reinforces a teacher's voice; Mimio MyBot system for robotics learning; Robo3D printers; MyStemKits, which offers lesson plans for grades K-12 math and science teachers; MimioView document camera; EzRoom, an integrated AV solution; Lyrik, an amplification solution; and Conductor School Communication System, an IP-based campus-wide communication and control solution; and accessories, such as mobile carts, installation accessories, and wall-mount accessories for interactive LED flat-panels and audio solutions. Further, it offers classroom training, professional development, and educator certification services. The company was formerly known as Logical Choice Corporation. Boxlight Corporation was founded in 1985 and is headquartered in Duluth, Georgia.

TNF Pharmaceuticals stock logo

TNF Pharmaceuticals NASDAQ:TNFA

$1.79 -0.09 (-4.79%)
As of 09/4/2026

TNF Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company. It focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas